UBMD Pediatrics

Buffalo, New York 14203

4 studies enrolling now · 17 studies all time

What they study most

Allergy, Peanut, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Food Allergy, Growth Hormone Deficiency, Idiopathic Short Stature, Mitochondrial Diseases, Neurodegenerative Disease, Hereditary, Obesity, Optic Atrophy, Overweight, Type 1 Diabetes

Studies at this site

• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) — Recruiting now
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
• A Study to Assess Growth in Children With Idiopathic Short Stature — Recruiting now
• A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature — Recruiting now
• Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) — Completed
• Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) — Running, not enrolling
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes — Starting soon
• A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers — Completed
• A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus — Completed
• Long-term Extension Study of Ligelizumab in Food Allergy — Stopped early
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy — Stopped early
• A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes — Completed
• Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus — Stopped early
• Natural History Study of SLC25A46 Mutation-related Mitochondriopathy — Completed
• Natural History Study of FDXR Mutation-related Mitochondriopathy — Completed
• Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM — Completed
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes — Completed